TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -1 | 0 | -2 | 9 | 4 | 23 | 7 |
| S | %wins | 100 | 100 | 100 | 0 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/15/19 17:08 | 9/18/19 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kenyon Lawrence A | NJ | DO | CEO,P,CF | S.a | -2 | 1.70 | 0 | -1 | -13 | 9 | D | ||||||||||||||
9/23/19 17:09 | 9/18/19 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kenyon Lawrence A | NJ | DO | CEO,P,CF | S | -2 | 1.70 | 0 | -1 | -2 | 81 | D | ||||||||||||||
9/18/18 16:56 | 9/18/18 | ONS | Oncobiologics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kenyon Lawrence A | NJ | DO | CEO,P,CF | S | -9 | 0.8720 | 0 | -10 | -15 | 57 | D | ||||||||||||||
12/26/17 17:04 | 12/22/17 | ONS | Oncobiologics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kenyon Lawrence A | NJ | O | CFO,Secr | S | -30 | 1.13 | 0 | -26 | -28 | 67 | D | ||||||||||||||
3/3/10 18:25 | 3/3/10 | PRX | Par Pharmaceutical Companies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kenyon Lawrence A | NJ | O | EVP,CFO | S.d | -540 | 25.20 | 12 | -21 | -51 | 21 | D | 42 | 111 | 23 | 5 | -7 | 5 | -1 | 0 | -1 | 0 | -2 | 9 | 4 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |